| 标题 |
Transarterial chemoembolization combined with immunotherapy plus bevacizumab or lenvatinib for the treatment of unresectable hepatocellular carcinoma: which treatment strategy demonstrates superior efficacy? |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hepatobiliary Surgery and Nutrition 作者:Wendi Kang; Hang Li; Qicai Lian; Siyuan Weng; Xuan Zhou; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)